Pfizer quarterly revenue soars 19.7%
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] US drugmaker Pfizer Inc reported a 19.7 per cent rise in quarterly revenue, boosted by sales of its new treatments for cancer and its Hospira acquisition.
The company's revenue rose to US$13.01 billion in the first quarter, from US$10.86 billion a year earlier.
Net income rose to US$3.02 billion, or 49 cents per share, from US$2.38 billion, or 38 cents per share.
Pfizer and Allergan Inc walked away from their US$160 billion merger in April, citing new US Treasury rules aimed at blocking the deal's tax benefits.
REUTERS
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
